Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...

慢性阻塞性肺疾病（COPD）危害大且现有疗法存在局限。研究人员开展橙皮素（HE）治疗 COPD 的研究，经网络药理学、分子对接和动物实验，发现 HE 可改善肺功能、减轻炎症，机制可能是抑制 MAPKs 和 NF-κB 信号通路，为 COPD 治疗带来新希望。

Given the rising prevalence of cognitive impairment in COPD, researchers have called for increased efforts to identify risk ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

Due to the destructive nature of COPD on patients’ lungs and well-being, timely diagnosis is key, and integrating spirometry ...

We are proud to announce that Natalia Hernandez-Pacheco, a postdoctoral researcher at the Department of Clinical Research and ...

Early diagnosis of COPD, chronic obstructive pulmonary disease, increases the quality of life of the patient and the efficacy ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

慢性阻塞性肺疾病（COPD）患者存在上皮修复缺陷，目前缺乏有效治疗药物。研究人员以肺成纤维细胞分泌组为切入点，开展相关研究。结果发现骨糖蛋白（OGN）及其活性片段可促进肺泡上皮修复，改善肺功能，有望成为 COPD 治疗的新策略。